prostatic neoplasms, Castration-Resistant

Preferred Label : prostatic neoplasms, Castration-Resistant;

MeSH definition : Tumors or cancer of the PROSTATE which can grow in the presence of low or residual amount of androgen hormones such as TESTOSTERONE.;

MeSH synonym : Castration-Resistant prostatic neoplasm; neoplasm, Castration-Resistant prostatic; neoplasms, Castration-Resistant prostatic; prostatic neoplasm, Castration-Resistant; prostatic neoplasms, castration resistant; Androgen-Insensitive prostatic neoplasms; androgen insensitive prostatic neoplasms; Androgen-Resistant prostatic neoplasms; androgen resistant prostatic neoplasms; prostatic neoplasms, hormone refractory; hormone refractory prostatic neoplasms; prostatic neoplasms, Androgen-Independent; Androgen-Independent prostatic neoplasm; neoplasm, Androgen-Independent prostatic; neoplasms, Androgen-Independent prostatic; prostatic neoplasm, Androgen-Independent; prostatic neoplasms, androgen independent; prostatic neoplasms, Androgen-Insensitive; Androgen-Insensitive prostatic neoplasm; neoplasm, Androgen-Insensitive prostatic; neoplasms, Androgen-Insensitive prostatic; prostatic neoplasm, Androgen-Insensitive; prostatic neoplasms, androgen insensitive; prostatic neoplasms, Androgen-Resistant; Androgen-Resistant prostatic neoplasm; neoplasm, Androgen-Resistant prostatic; neoplasms, Androgen-Resistant prostatic; prostatic neoplasm, Androgen-Resistant; prostatic neoplasms, androgen resistant; Androgen-Independent prostatic neoplasms; androgen independent prostatic neoplasms; Castration-Resistant prostatic neoplasms; castration resistant prostatic neoplasms;

MeSH hyponym : prostatic cancer, Castration-Resistant; Cancer, Castration-Resistant Prostatic; Cancers, Castration-Resistant Prostatic; Castration-Resistant Prostatic Cancers; Prostatic Cancer, Castration Resistant; Prostatic Cancers, Castration-Resistant; Androgen-Insensitive Prostatic Cancer; Androgen Insensitive Prostatic Cancer; Androgen-Resistant Prostatic Cancer; Androgen Resistant Prostatic Cancer; Prostatic Cancer, Hormone Refractory; Hormone Refractory Prostatic Cancer; Prostatic Cancer, Androgen-Independent; Androgen-Independent Prostatic Cancers; Cancer, Androgen-Independent Prostatic; Cancers, Androgen-Independent Prostatic; Prostatic Cancer, Androgen Independent; Prostatic Cancers, Androgen-Independent; Prostatic Cancer, Androgen-Insensitive; Androgen-Insensitive Prostatic Cancers; Cancer, Androgen-Insensitive Prostatic; Cancers, Androgen-Insensitive Prostatic; Prostatic Cancer, Androgen Insensitive; Prostatic Cancers, Androgen-Insensitive; Prostatic Cancer, Androgen-Resistant; Androgen-Resistant Prostatic Cancers; Cancer, Androgen-Resistant Prostatic; Cancers, Androgen-Resistant Prostatic; Prostatic Cancer, Androgen Resistant; Prostatic Cancers, Androgen-Resistant; Androgen-Independent Prostatic Cancer; Androgen Independent Prostatic Cancer; Castration-Resistant Prostatic Cancer; Castration Resistant Prostatic Cancer;

Details

Origin ID

D064129;

UMLS CUI

C3658267;

Allowable qualifiers
- blood [MeSH Qualifier]
- blood supply [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemically induced [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- complications [MeSH Qualifier]
- congenital [MeSH Qualifier]
- diagnosis [MeSH Qualifier]
- diagnostic imaging [MeSH Qualifier]
- diet therapy [MeSH Qualifier]
- drug therapy [MeSH Qualifier]
- economics [MeSH Qualifier]
- embryology [MeSH Qualifier]
- enzymology [MeSH Qualifier]
- epidemiology [MeSH Qualifier]
- ethnology [MeSH Qualifier]
- etiology [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- microbiology [MeSH Qualifier]
- mortality [MeSH Qualifier]
- nursing [MeSH Qualifier]
- parasitology [MeSH Qualifier]
- pathology [MeSH Qualifier]
- physiopathology [MeSH Qualifier]
- prevention and control [MeSH Qualifier]
- psychology [MeSH Qualifier]
- radiotherapy [MeSH Qualifier]
- rehabilitation [MeSH Qualifier]
- secondary [MeSH Qualifier]
- surgery [MeSH Qualifier]
- therapy [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
- urine [MeSH Qualifier]
- veterinary [MeSH Qualifier]
- virology [MeSH Qualifier]
Currated CISMeF NLP mapping
- Castration-Resistant Prostate Carcinoma [NCIt concept]
- Castration-resistant prostate cancer [MedDRA LLT]
DO Cross reference
- castration-resistant prostate carcinoma [DO Concept]
Record concept(s)
- prostatic cancer, Castration-Resistant [MeSH concept]
- prostatic neoplasms, Castration-Resistant [MeSH concept]
See also
- androgen receptor antagonists [MeSH Descriptor]
- receptors, androgen [MeSH Descriptor]
See also (suggested by CISMeF)
- drug resistance, neoplasm [MeSH Descriptor]
Semantic type(s)
- Neoplastic Process [UMLS semantic type]
Validated automatic mappings to BTNT
- Hormone refractory prostate cancer (disorder) [SNOMED CT concept]
- castration resistant prostate cancer [Disease (Nov.)]
- hormone refractory prostate cancer [Disease (Nov.)]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients